Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-055811
Filing Date
2013-10-31
Accepted
2013-10-31 08:35:53
Documents
1
Period of Report
2013-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd393873.html 4  
1 FORM 4 rrd393873.xml 4 29628
  Complete submission text file 0001181431-13-055811.txt   31133
Mailing Address C/O AEGERION PHARMACEUTICALS 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 131180942

Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations